Tick-host-pathogen interactions in Lyme borreliosis

Trends in Parasitology

Volumn 23, Issue 9, 2007, Pages 434-438

  Hovius, Joppe W R ^a,c   van Dam, Alje P ^b   Fikrig, Erol ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; LYME DISEASE VACCINE; RECOMBINANT PROTEIN; TROSPA VACCINE; UNCLASSIFIED DRUG;

BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BORRELIA BURGDORFERI; DISEASE CARRIER; GENE EXPRESSION; HOST PATHOGEN INTERACTION; IXODES; LYME DISEASE; NONHUMAN; REVIEW; TICK;

ANIMALS; ANTIGENS, SURFACE; ARACHNID VECTORS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; GENE EXPRESSION REGULATION; HOST-PARASITE RELATIONS; HUMANS; IXODES; LYME DISEASE; RECEPTORS, CELL SURFACE;

ARTHROPODA; BORRELIA BURGDORFERI; IXODES; IXODES SCAPULARIS; IXODIDA; SPIROCHAETALES; VERTEBRATA;

EID: 34547965447     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.07.001     Document Type: Review

References (60)

1. Wang G., et al. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin. Microbiol. Rev. 12 (1999) 633-653
2. van Dam A.P., et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17 (1993) 708-717
3. Steere A.C. Lyme disease. N. Engl. J. Med. 345 (2001) 115-125
4. Fraser C.M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390 (1997) 580-586
5. Barbour A.G. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent. J. Clin. Microbiol. 26 (1988) 475-478
6. Casjens S., et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35 (2000) 490-516
7. Guo B.P., et al. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63 (1995) 3467-3472
8. Hellwage J., et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 276 (2001) 8427-8435
9. Kraiczy P., et al. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur. J. Immunol. 31 (2001) 1674-1684
10. Neelakanta G., et al. Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within ixodes ticks. PLoS. Pathog. 3 (2007) e33
11. Pal U., et al. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 119 (2004) 457-468
12. Probert W.S., and Johnson B.J. Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol. Microbiol. 30 (1998) 1003-1015
13. Ramamoorthi N., et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436 (2005) 573-577
14. Garg R., et al. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J. Immunol. 177 (2006) 6579-6583
15. Neeleman C., et al. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect. Immun. 67 (1999) 4517-4524
16. Ram S., et al. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol. Immunol. 36 (1999) 915-928
17. Alitalo A., et al. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect. Immun. 69 (2001) 3685-3691
18. Alitalo A., et al. Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J. Immunol. 169 (2002) 3847-3853
19. Kurtenbach K., et al. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect. Immun. 66 (1998) 1248-1251
20. Stevenson B., et al. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect. Immun. 70 (2002) 491-497
21. Suk K., et al. Borrelia burgdorferi genes selectively expressed in the infected host. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4269-4273
22. Fikrig E., et al. Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J. Immunol. 164 (2000) 5344-5351
23. Brown E.L., et al. Resistance to Lyme disease in dEcoRIn-deficient mice. J. Clin. Invest. 107 (2001) 845-852
24. Feng S., et al. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect. Immun. 66 (1998) 2827-2835
25. Seshu J., et al. Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol. Microbiol. 59 (2006) 1591-1601
26. Li X., et al. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect. Immun. 74 (2006) 3305-3313
27. Liang F.T., et al. Molecular adaptation of Borrelia burgdorferi in the murine host. J. Exp. Med. 196 (2002) 275-280
28. Liang F.T., et al. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect. Immun. 72 (2004) 5759-5767
29. Anguita J., et al. Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination. J. Immunol. 167 (2001) 3383-3390
30. Zhang J.R., et al. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89 (1997) 275-285
31. Wang G., et al. Analysis of a VMP-like sequence (vls) locus in Borrelia garinii and Vls homologues among four Borrelia burgdorferi sensu lato species. FEMS Microbiol. Lett. 199 (2001) 39-45
32. Zhang J.R., and Norris S.J. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect. Immun. 66 (1998) 3698-3704
33. Liang F.T., et al. Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl. J. Bacteriol. 182 (2000) 3597-3601
34. McDowell J.V., et al. Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes. Infect. Immun. 70 (2002) 4196-4203
35. Lawrenz M.B., et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37 (1999) 3997-4004
36. Eicken C., et al. Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi. J. Biol. Chem. 277 (2002) 21691-21696
37. Nosbisch L.K., and de Silva A.M. Lack of detectable variation at Borrelia burgdorferi vlsE locus in ticks. J. Med. Entomol. 44 (2007) 168-170
38. Narasimhan S., et al. Borrelia burgdorferi transcriptome in the central nervous system of non-human primates. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15953-15958
39. Alland D., et al. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13227-13232
40. Narasimhan S., et al. Examination of the Borrelia burgdorferi transcriptome in Ixodes scapularis during feeding. J. Bacteriol. 184 (2002) 3122-3125
41. de Silva A.M., and Fikrig E. Arthropod- and host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 99 (1997) 377-379
42. Montgomery R.R., et al. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183 (1996) 261-269
43. Schwan T.G., et al. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2909-2913
44. Yang X.F., et al. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 199 (2004) 641-648
45. Pal U., et al. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Invest. 106 (2000) 561-569
46. Pal U., et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113 (2004) 220-230
47. Grimm D., et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3142-3147
48. Anguita J., et al. Salp15, an Ixodes scapularis salivary protein, inhibits CD4(+) T cell activation. Immunity 16 (2002) 849-859
49. Hovius, J.W. et al. Identification of Salp15 homologues in Ixodes ricinus ticks. Vector Borne Zoonotic Dis. (in press)
50. Wikel S.K., and Bergman D. Tick-host immunology: significant advances and challenging opportunities. Parasitol. Today 13 (1997) 383-389
51. Wikel S.K. Tick modulation of host immunity: an important factor in pathogen transmission. Int. J. Parasitol. 29 (1999) 851-859
52. De la Fuente J., and Kocan K.M. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol. 28 (2006) 275-283
53. Labuda M., et al. An antivector vaccine protects against a lethal vector-borne pathogen. PLoS. Pathog. 2 (2006) e27
54. De la Fuente J., et al. The tick protective antigen, 4D8, is a conserved protein involved in modulation of tick blood ingestion and reproduction. Vaccine 24 (2006) 4082-4095
55. Ribeiro J.M., et al. An annotated catalog of salivary gland transcripts from Ixodes scapularis ticks. Insect Biochem. Mol. Biol. 36 (2006) 111-129
56. Tsao J.I., et al. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18159-18164
57. Tsao J., et al. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks. Vector Borne Zoonotic Dis. 1 (2001) 65-74
58. Fikrig E., et al. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250 (1990) 553-556
59. Fikrig E., et al. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J. Infect. Dis. 164 (1991) 1224-1227
60. Das S., et al. Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J. Infect. Dis. 184 (2001) 1056-1064